Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOREISAN-HF
NCT04691700Phase 4Active, not recruiting
- Start
- Jan 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oreongsan in heart failure (HF), edema. Started Jan 2021; status: active, not recruiting.
02
Drugs
oreongsan
03
Conditions
heart failure (HF)edema
Beyond the preview
Go deeper on NCT04691700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04691700.